Easom Eric bought ANTX

February 20, 2026 · Form 4 insider transaction

Easom Eric bought 112,250 shares of AN2 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
112,250
Price
$0.00
Total value
N/A
InsiderEasom Eric
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 20, 2026
Filing dateFebruary 23, 2026
Shares owned after368,630
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.; Includes a balance of (i) 145,250 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025 and (ii) 99,000 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, in each case subject to the Reporting Person's continuous service through each applicable vesting date.

View the original Form 4 on SEC EDGAR